171 Results

People

  1. Myskowski
    Myskowski
  2. Busam
    Busam
  3. Lacouture
    Lacouture
  4. Motzer
    Motzer
  5. Pulitzer
    Pulitzer
  6. Saltz
    Saltz
  7. Balagula
    Balagula
  8. Cheung
    Cheung
  9. Dusza
    Dusza
  10. Halpern
    Halpern

Groups

  1. Department of Medicine (98)
  2. Division of Subspecialty Medicine (52)
  3. Survivorship Research (50)
  4. Solid Tumor Oncology Division (48)
  5. Dermatology (45)
  6. Dermatology Service (44)
  7. Melanoma Disease Management Team (30)
  8. Department of Pathology and Laboratory Medicine (29)
  9. Hematologic Malignancies, Division of (25)
  10. Surgery (25)
  1. "erythema"
Formats
  1. Journal Article (161)
  2. Review (4)
  3. Conference Paper (2)
  4. Guidelines (2)
  5. Miscellaneous (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (98)
  2. Division of Subspecialty Medicine (52)
  3. Survivorship Research (50)
  4. Solid Tumor Oncology Division (48)
  5. Dermatology (45)
  6. Dermatology Service (44)

More Groups

People
  1. Mario Lacouture (17)
  2. Patricia Myskowski (11)
  3. Klaus Busam (9)
  4. Robert Motzer (9)
  5. Melissa Pulitzer (8)
  6. Leonard Saltz (7)

More People

Years
  1. 2025 (4)
  2. 2024 (12)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. International Journal of Radiation Oncology, Biology, Physics (8)
  3. Journal of the American Academy of Dermatology (8)
  4. Lancet Oncology (5)
  5. Blood (4)
  6. Investigational New Drugs (4)

More Publications

Publishers
  1. Elsevier Inc. (29)
  2. Springer (13)
  3. Wiley Blackwell (13)
  4. Lippincott Williams & Wilkins (11)
  5. American Society of Clinical Oncology (9)
  6. Mosby Elsevier (9)

More Publishers

Results (171)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Features of an atypical vascular lesion on dermoscopy, reflectance confocal microscopy, and optical coherence tomography
    Journal Article

    Zugaib Abdalla, B. M.; Posner, J.; Harris, U.; Reiter, O.; Payulert, C. M.; Lezcano, C.; Marghoob, A. A.; Jain, M.
    JAAD Case Reports (2023)

    Fulltext@MSK | Save
  • The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions
    Guidelines

    Dvorak, C. C.; Haddad, E.; Heimall, J.; Dunn, E.; Buckley, R. H.; Kohn, D. B.; Cowan, M. J.; Pai, S. Y.; Griffith, L. M.; Cuvelier, G. D. E.; more...
    Journal of Allergy and Clinical Immunology (2023)

    Fulltext@MSK | Save
  • A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
    Journal Article

    Rosenbaum, E.; Chugh, R.; Ryan, C. W.; Agulnik, M.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: Final results from the BFORE trial
    Journal Article

    Brümmendorf, T. H.; Cortes, J. E.; Milojkovic, D.; Gambacorti-Passerini, C.; Clark, R. E.; le Coutre, P.; Garcia-Gutierrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Simplified graded infusion strategy for mitigation of oxaliplatin hypersensitivity
    Journal Article

    Alonso Martinez, S.; Segal, N. H.; Cercek, A.; Yaeger, R.; Stadler, Z.; Kemeny, N. E.; Nusrat, M.; Shahrokni, A.; Connell, L.; Saltz, L. B.
    Clinical Colorectal Cancer (2022)

    Fulltext@MSK | Save
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: A rare clinical reaction
    Journal Article

    Hoff, N. P.; Freise, N. F.; Schmidt, A. G.; Firouzi-Memarpuri, P.; Reifenberger, J.; Luedde, T.; Bölke, E.; Meller, S.; Homey, B.; Feldt, T.; more...
    European Journal of Medical Research (2021)

    Fulltext@MSK | Save
  • How we treat mycosis fungoides and Sézary syndrome
    Journal Article

    Khan, N.; Noor, S. J.; Horwitz, S.
    Clinical Advances in Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Characterization and management of ERK inhibitor associated dermatologic adverse events: Analysis from a nonrandomized trial of ulixertinib for advanced cancers
    Journal Article

    Wu, J.; Liu, D.; Offin, M.; Lezcano, C.; Torrisi, J. M.; Brownstein, S.; Hyman, D. M.; Gounder, M. M.; Abida, W.; Drilon, A.; more...
    Investigational New Drugs (2021)

    Fulltext@MSK | Save
  • CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: An open-label, multicentre, phase 1b study
    Journal Article

    O'Hara, M. H.; O'Reilly, E. M.; Varadhachary, G.; Wolff, R. A.; Wainberg, Z. A.; Ko, A. H.; Fisher, G.; Rahma, O.; Lyman, J. P.; Cabanski, C. R.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save